299660.KQ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 09:30):

Stats
Dzisiejszy wolumen	18 207.00
Średni wolumen	59 017.00
Kapitalizacja rynkowa	52.17B
EPS	KRW-370.82 ( 2023-06-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW3.38 (0.09%)

Wolumen Korelacja

Długi: 0.08 (neutral)

Krótki: -0.52 (weak negative)

Signal:(56.397) Neutral

Cellid, Co., Ltd. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cellid, Co., Ltd. Korelacja - Waluta/Towar

0.81
( strong )

-0.49
( neutral )

0.67
( moderate )

-0.79
( moderate negative )

Cellid, Co., Ltd. Finanse

Annual	2023
Przychody:	KRW0
Zysk brutto:	KRW-2.66B (0.00 %)
EPS:	KRW-1 078.05

FY	2023
Przychody:	KRW0
Zysk brutto:	KRW-2.66B (0.00 %)
EPS:	KRW-1 078.05

FY	2022
Przychody:	KRW480.00M
Zysk brutto:	KRW-2.38B (-495.54 %)
EPS:	KRW-2 141.24

Financial Reports:

No articles found.

Cellid, Co., Ltd.

Cellid, Inc. develops immunothetherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and genital cancer with human papilloma virus antigen; BVAC-B for gastric, ovarian, lung, and pancreatic cancer with HER-2/neu antigen; and BVAC-P for prostate, urinary tract, and brain cancer with PAP/PSMA antigens. The company is also developing BVAC-M for cancers, such as melanoma with GP100/MAGE-A3 antigens; and BVAC-Neo, a customized immunotherapeutic vaccine. Cellid, Inc. was founded in 2006 and is based in Seoul, South Korea.